Mumbai/IBNS, April 27 -- Shares of Sun Pharmaceutical Industries surged over 7% on Monday after the drug major announced the acquisition of US-based global healthcare firm Organon & Co. in one of the largest overseas deals by an Indian company.

$11.75 Billion All-Cash Deal

Sun Pharma will acquire all outstanding shares of Organon at $14 per share in an all-cash transaction, valuing the deal at an enterprise value of $11.75 billion.

Strengthening Global Presence

Organon is a global leader in women's health, with a portfolio of over 70 products spanning:

The company operates across 140 countries, with key markets including the US, Europe, China, Canada, and Brazil.

Robust Manufacturing Network

Organon's global footprint is supported ...